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ABSTRACT 
HIGH DIVERSITY OF TRYPANOSOMA CRUZI DISCRETE TYPING UNITS 
CIRCULATING IN TRIATOMA IN WESTERN MEXICO 
by 
Uyen Tran Thuong Nguyen 
November 2016 
Chagas disease is caused by the protozoan parasite Trypanosoma cruzi, which is 
transmitted to domestic and sylvatic mammals via the feces of hematophagous hemiptera 
of the subfamily Triatominae (Reduviidae). Trypanosoma cruzi is found only in the 
Americas and displays remarkable genetic diversity. Seven discrete typing units (DTUs) 
are currently recognized (TcI–TcVI and TcBat). In Jalisco, Mexico, where Chagas 
disease has a high prevalence rate, TcI has historically been the only DTU reported. This 
study focused on the molecular identification of T. cruzi DTUs circulating in Triatoma 
near the Estación de Biología Chamela, on the southwest coast of Jalisco, Mexico. I 
collected DNA from 95 Triatoma bugs. Trypanosoma cruzi infection was detected using 
PCR primers specific for the minicircle variable region of the parasite’s kinetoplast DNA 
(kDNA). Trypanosoma cruzi DTUs were identified by amplifying the intergenic region 
of the mini-exon, and the genes 24Sα, 18S, TcSC5D, and TcMK. Two species of Triatoma 
were collected, Triatoma longipennis and T. bolivari, with an overall infection rate of 
59%. There was high genetic diversity of T. cruzi in my samples, with the DTUs TcI, 
TcII, TcIV, TcVI, and Tcbat being identified. This is the first report of TcVI and Tcbat in 
North America. In the Triatoma found to be infected, 96% had TcI, 35% TcII, 2% TcIV, 
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25% TcVI, and 2% Tcbat. Several vertebrate hosts for Triatoma were also identified 
from visible blood within Triatominaes’ gut using PCR primers for cytochrome b and 
cytochrome oxidase subunit I genes. My observations indicate a much higher diversity of 
T. cruzi DTUs in Triatoma than previously reported in Jalisco. The results have important 
implications for understanding the geographical distribution of T. cruzi DTUs and 
epidemiology of Chagas disease in Mexico.  
Keywords: Trypanosoma cruzi, Genotyping, Discrete typing units (DTUs), Triatoma 
longipennis, Triatoma bolivari, Seasonally dry tropical forest, Jalisco, Mexico. 
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CHAPTER I 
INTRODUCTION 
Chagas disease (American trypanosomiasis) is caused by infection with Trypanosoma 
cruzi, a parasitic protozoan found in mammals wherever Triatominae insect vectors are found, 
between approximately 40o N and S of the equator in the Americas ("Who, how, what and 
where ?" 2010). Chagas disease is listed by WHO as one of the top 17 most neglected tropical 
diseases that is caused by bacterial and parasitic infection, alongside ascariasis, trichuriasis, 
hookworm infection, leishmanisasis, and human African trypanosomiasis (Molyneux et al. 
2016). Chagas disease is responsible for disability and early death in approximately one-third of 
those infected (Carabarin-Lima et al. 2013). The WHO reports that approximately 5-6 million 
individuals are infected with Chagas disease, more than 25 million are at risk, and 10,000 die 
each year in endemic areas (WHO 2010; 2015). Chagas disease has been increasingly detected in 
the US, Canada, and many European and Asian countries due to human migration between Latin 
America and the rest of the world (Coura and Viñas 2010). 
In Mexico, it is estimated that 1.1 to 2 million people are infected with Chagas disease, 
predominately through vector-borne exposure (Carabarin-Lima et al. 2013). Trypanosoma cruzi 
infection has also increasingly been transmitted via blood transfusion(Carabarin-Lima et al. 
2013), although mandatory serological screening nationwide is reducing this risk (Sánchez-
González et al. 2016). In addition, there is no consensus on diagnostic methods and trypanocidal 
treatment is not administered to chronic patients (Carabarin-Lima et al. 2013). The disease is also 
becoming more urbanized due to human migration from rural areas to Mexican cities, mostly in 
search of jobs (Guzmán-Bracho 2001). There are 18 regions in Mexico, all rural, that have 
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endemic T. cruzi transmission, including the states of Oaxaca, Jalisco, Yucatan, Chiapas, 
Veracruz, Puebla, Guerrero, Hidalgo, and Morelos (Carabarin-Lima et al. 2013).  
Due to a high genetic diversity, Trypanosoma cruzi is classified into 7 strains, known as 
discrete typing units (DTUs), namely TcI, TcII , TcIII , TcIV , TcV , TcVI, and Tcbat (Zingales 
et al. 2012). The dominant strain of T. cruzi in Mexico is TcI (Bosseno et al. 2002; Brenière et al. 
2007), but recent studies have indicated other DTUs (TcII, III, IV, V) circulating in Triatominaes 
in Veracruz and Michoacán, Mexico (Ramos-Ligonio et al. 2012; Ibáñez-Cervantes et al. 2013). 
One study also reported many patients in Mexico were seropositive for TCII, which includes 
DTUs TcII-VI (Risso et al. 2011). These studies suggest either that the diversity of T. cruzi 
strains in Mexico is growing, or increased sampling has led to a better understanding of the 
complexity of DTUs within Mexico.  
Jalisco has the highest prevalence of T. cruzi infection in Mexico, as 12% of the 
population was found to be seropositive (Carabarin-Lima et al. 2013), and only TcI has been 
previously reported there (Bosseno et al. 2002; Brenière et al. 2007). However, Jalisco is 
adjacent to Michoacán, where multiple T. cruzi DTUs have been identified (Ibáñez-Cervantes et 
al. 2013). Given these findings, Jalisco could potentially have greater diversity of T. cruzi DTUs 
than previously reported.  
My study explores the prevalence and diversity of potential T. cruzi DTUs within their 
sylvatic Triatoma insect vectors inhabiting a tropical dry forest reserve in coastal Jalisco, 
Mexico. My objectives were to (a) evaluate the prevalence of T. cruzi in the local Triatominae, 
(b) determine the T. cruzi DTUs and haplotypes present in the region, (c) identify Triatominae 
vectors encountered near Estación de Biología Chamela (EBCh) in Jalisco, Mexico, and (d) 
when possible, determine which vertebrates are serving as hosts for Triatominae. 
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CHAPTER II 
LITERATURE REVIEW 
Brief Background 
Trypanosoma is a genus in the class Kinetoplastida, and a monophyletic group of 
flagellated protozoa that is exclusively parasitic. Several trypanosomes cause serious disease in 
humans, Trypanosoma brucei gambiense and T.b. rhodesiense cause African trypanosomiasis 
(sleeping sickness), while Trypanosoma cruzi causes American trypanosomiasis (Chagas 
disease). Chagas disease was discovered by a Brazilian scientist Carlos Chagas (1879-1934) in 
1909. He found a flagellated parasite in the intestine of a blood-sucking (hematophagous) bug 
and he named it T. cruzi after his mentor Oswald Cruz, the founder of the Oswaldo Cruz Institute 
in Brazil (Junqueira et al. 2010). After his discovery of Chagas disease, significant progress has 
been made in many aspects of this disease, including increased understanding of its 
epidemiology, parasite genome, immunology, and host-parasite interactions (Junqueira et al. 
2010). However, it is still a serious public health concern in Latin America and non-endemic 
areas due to human migration (Brener and Gazzinelli 1997; El-sayed et al. 2005). 
Chagas disease is transmitted to humans and mammals by blood-sucking bugs, which 
belong to the subfamily Triatominae (Hemiptera: Reduviidae). The disease is found in wildlife 
anywhere the vectors are found, from Argentina up to approximately 40o North latitude in the 
Americas (2010). These bugs are attracted to warmth and CO2 exhaled from mammals; therefore 
they usually bite the victims near their mouth at night while sleeping. Because of this, they have 
been nicknamed kissing bugs. Other common names are conenose bug, assassin bug, and 
triatomine bug. There are more than 130 species of kissing bugs, but only a few are known 
vectors for Chagas disease (Lent and Wygodzinsky 1979). Charles Darwin, in Voyage of the 
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Beagle, described being bitten by a kissing bug during his field trips to the Argentine pampas 
(Rassi et al. 2010). He later suffered debilitating symptoms consistent with Chagas disease 
infection (Rassi et al. 2010). Interestingly, T. cruzi DNA has been found in 9000-year-old 
mummified human tissues in northern Chile; the disease is believed to have been in the New 
World for 7-10 million years, long before humans migrated into the Americas (Aufderheide et al. 
2004; Steverding 2014).  
Morphology and Life Cycle 
Trypanosoma cruzi is a eukaryotic single-celled flagellate. Besides having a nucleus, it 
possesses a single large and highly modified mitochondrian containing a network of circular 
DNA (called kinetoplast DNA or kDNA) that contain many copies of the mitochondrial genome. 
T. cruzi transitions between three different forms (epimastigote, trypomastigote, and amastigote) 
in its life cycle when it travels from its vector (kissing bugs) to its mammalian host (Fig. 1). The 
epimastigote and trypomastigote have a single flagellum that enables movement and attachment 
to the surface of the host cell (De Souza 1999). Epimastigotes are found in the intestinal tract of 
kissing bugs, are about 20 microns in length, and divide via binary fission. Its kDNA is 
positioned in the middle of the body, adjacent to the base of the flagellum posteriorly, and to 
nucleus anteriorly. Trypomastigotes are found in the blood stream of infected hosts. They are 15-
25 microns in length and do not divide. Its kDNA is found at the most posterior portion of its 
body, adjacent anteriorly to the base of flagellum. The nucleus is found in the middle of the 
body. It has a characteristic C-shape if stained with Giemsa stains. Amastigotes live 
intracellularly, lack a flagellum and are among the smallest known eukaryotic cells (2.5–5 μm 
wide). Amastigotes are found within the cytoplasm of nucleated cells in their mammalian hosts. 
This stage is oval and is the dividing form within mammals.  
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Fig. 1 Schematic illustration of Trypanosoma cruzi stages. Morphological differences included 
the size of each stage and the location of kDNA, nucleus, and flagellum. (A) Epimastigote, (B) 
Trypomastigote, (C) Amastigote (Schuster and Sullivan 2002). 
The life cycle of T. cruzi starts when a kissing bug takes a blood meal from an infected 
mammalian host (Fig. 2). Blood containing trypomastigotes is ingested by the insect vector. The 
trypomastigotes transform into epimastigotes in the digestive tract of the bug. Epimastigotes 
differentiate into metacylic trypomastigotes in the feces of the kissing bug. During the blood 
meal, the infected bug defecates on the host, releasing highly infective parasites onto the source 
of the bloodmeal. The parasites are not passed by the bite itself. Metacylic trypomastigotes in the 
defecant enter the mammalian host’s body through the bite wound, broken skin, or intact 
mucosal membranes. Inside the host, trypomastigotes enter the host nucleated cells and 
transform into a dividing form, amastigotes. Amastigotes mutiply inside the host cell until it 
ruptures, allowing them to invade other healthy cells.  
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Fig. 2 Life cycle of Trypanosoma cruzi (Centers for Disease Control and Prevention 2015). 
Chagas Disease 
Acute phase 
There are three phases of Chagas infection: acute, indeterminate, and chronic phases. The 
acute phase occurs after T. cruzi enters the victim’s body and lasts for 4-8 weeks (Rassi et al. 
2010). Most cases will pass unnoticed because the clinical symptoms are nonspecific and typical 
for many infections. Victims have flu-like symptoms, such as fever, nausea, vomiting, and 
diarrhea. An inflammatory lesion at the T. cruzi entry site (chagoma) and enlarged lymph nodes, 
liver, and/or spleen may be observed in the acute phase. If the entry point is the eye, it may cause 
swelling of the eye (Romana’s sign) and conjunctivitis. Circulating trypomastigotes in blood are 
easily found during the acute phase. Acute infection can be cured with antiparasitic drugs such as 
benznidazole and nifurtimox (Rassi et al. 2010). Death may occur (<5-10%) in acute infected 
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individuals, often in children (4 years old or younger), from severe myocarditis and/or 
meningoencephalitis (Rassi et al. 2010).  
When Chagas disease is transmitted congenitally by an infected mother during 
pregnancy, infected new born babies may develop acute symptoms at birth or a few weeks after 
birth, including hypotonicity, fever, hepatosplenomegaly, anemia, prematurity, low birth weight, 
and low Apgar score (Rassi et al. 2010). Miscarriage and placentitis can also occur during 
pregnancy due to maternal infection (Rassi et al. 2010). 
Intermediate and chronic phases 
After 8-12 weeks of the initial infection, the parasitemia becomes undetectable by 
microscopy and, without appropriate treatment, infected individuals will enter the intermediate 
form of Chagas disease (Bern et al. 2011). Patients may have a positive serological test, but 
never develop any clinical manifestations, and the parasite will be maintained for life (Machado 
et al. 2012). In some cases, individuals might not be aware of their infection but remain a 
potential source of T. cruzi transmission to vectors and humans (Bern et al. 2011). 
 Approximately, 30%-40% of infected individuals will develop the chronic phase of 
Chagas disease, which occurs 10-30 years after the initial infection (Rassi et al. 2010). Pathology 
of chronic Chagas disease, involved in heart, esophagus and colon, is classified into three clinical 
manifestations: cardiac, digestive and cardiodigestive. Digestive form of chronic Chagas disease 
is often observed in southern cone of South America and is rarely found in northern South 
America and Central America (Bern et al. 2011). Geographic distribution of disease pathology 
may be associated with different strains of T. cruzi. However, it has not been established which 
strain leads to which disease pathology of Chagas disease. Physiological factors of hosts, such as 
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genetic background, mitochondrial dysfunction, and immune competence, may be involved in 
the outcomes of clinical manifestation (Machado et al. 2012).  
The digestive form occurs in 10-15% of those with chronic Chagas disease and is mainly 
found in the southern cone of South America: Argentina, Brazil, Chile, and Bolivia (Rassi et al. 
2010). In the digestive form, T. cruzi injures the enteric nervous system, which regulates the 
function of gastrointestinal (GI) tract, resulting in dilation of organs of the GI tract (Machado et 
al. 2012). Although the enlargement of esophagus (megaoesophagus) and colon (megacolon) are 
the most common manifestations, enlargement of stomach, duodenum, jejunum, gallbladder, and 
choledochus are observed in some cases (Machado et al. 2012). Megaoesophagus causes 
difficulty in swallowing, regurgitation, excess salivation and malnutrition (Rassi et al. 2010). 
Megacolon, often occurring at the sigmoid segment, rectum, and descending colon, causes 
prolonged constipation, abdominal distension, and bowel obstruction (Rassi et al. 2010). Patients 
with megaoesophagus are more likely to develop esophagus cancer. However, colon cancer is 
not associated in patients with megacolon (Rassi et al. 2010). These clinical manifestations can 
ultimately lead to death in severe cases (Rassi et al. 2010).  
The cardiac form occurs in 20-30% of individuals with chronic phase and is the most 
serious manifestation of chronic Chagas disease. Pathogenesis is not completely understood but 
believed to be due to parasite persistence (Bern 2015). Cardiomyopathy, the main manifestation 
of cardiac form, is characterized by a chronic inflammatory process of the heart, including all 
chambers and the conduction system (Bern et al. 2011). To infect the heart, trypomastigotes must 
pass through layers of extracellular matrix (ECM) to reach cardiac myocytes. Invasion by T. 
cruzi results in myocardial damage, such as ischemia, inflammation, oxidative stress, and 
necrosis, which leads to ECM degradation (Machado et al. 2012). The earliest signs of affected 
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patient are often conduction-system abnormalities and multiform premature ventricular 
contraction (Bern 2015). Patients also display symptoms of cardiomyopathy, including sinus and 
junctional bradycardias, atrial fibrillation, atrioventricular blocks, and non-sustained or sustained 
ventricular tachycardia (Bern 2015). As the disease progresses, dilated cardiomyopathy and 
congestive heart failure might occur. These symptoms lead to palpitation, presyncope, and risk of 
sudden death. Apical aneurysm is a the hallmark of chronic Chagas disease and is believed to be 
a result of ECM degradation (Machado et al. 2012). In addition, strokes and thromboembolic 
events may occur as a result of the dilated left ventricle or aneurysm (Bern et al. 2011). Sudden 
death is typical in advanced cardiomyopathy and accounts for more than half of deaths (55-
65%), followed by heart failure, and thromboembolism (Rassi Jr et al. 2001). Thromboembolism 
can cause pulmonary and arterial embolization as well as stroke. Unexpected sudden death can 
also occur in patients with the indeterminate form of chronic Chagas disease, who do not have 
knowledge of their infection (Rassi Jr et al. 2001). 
Innate and Adaptive Immune Responses During T. cruzi Infection 
Innate and adaptive immune responses are two important parts of the human immune 
system. As its name suggests, the innate immune response consists of cells and proteins that 
humans are born with. It is responsible for non-specific defense mechanisms that will protect the 
body immediately against pathogens. The adaptive immune response is an antigen-specific 
mechanism and is initiated when the innate immune response fails to fight off the pathogen. 
Once a specific pathogen (antigen) is recognized and processed, the body will build up an army 
of specialized immune cells to overcome that specific pathogen. During the course of T. cruzi 
infection, the innate and adaptive immune systems play an important role for host survival and 
control of the parasite load. 
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Initial interaction of T. cruzi and host cells 
Metacyclic trypomastigotes have the ability to invade any nucleated host cells. Once they 
penetrate the human body through broken skin or mucosal membranes, they encounter host 
tissue cells and immune cells, but have a preference to invade non-phagocytic cells rather than 
immune cells (Padilla et al. 2009). This allows the trypomastigotes to avoid the early immune 
response present in the blood, allowing the persistence of acute Chagas infection (Padilla et al. 
2009). The parasite gains entry to the host cells in two ways: lysosome-dependent route or 
invagination of plasma membrane and fusion with lysosomes (Tardieux et al. 1992; Rodríguez et 
al. 1995; Rodríguez et al. 1996; Woolsey et al. 2003; Andrade and Andrews 2004). In both cases, 
it is confined to the host cell lysosome. A parasite-containing lysosome is called a 
parasitophorous vacuole. Lysosome fusion is necessary for a successful infection and 
trypomatigote-amastigote transformation (Woolsey et al. 2003; Andrade and Andrews 2004). 
The low pH environment of parasitophorous vacuoles activates a surface protein of the parasite 
called trans-sialidase. In the active form, trans-sialidase removes sialic acid, which is a 
protective coating on the inner layer of the parasitophorous vacuole and maintains the acidic 
environment. The absence of sialic acid ruptures the parasitophorous vacuole and releases 
trypomastigotes to the cytoplasm (Hall et al. 1992; Albertti et al. 2010). In the cytoplasm, the 
trypomastigotes transform into amastigotes. After several rounds of amastigote replication the 
infected cell bursts, releasing the parasites and allowing them to infect neighboring cells or travel 
in the blood stream to other parts of the body. 
Pattern-recognition receptors 
Pattern-recognition receptors (PRRs) are one of the first lines of host defense against T. 
cruzi and are expressed by cells of the innate immune response (Gazzinelli and Denkers 2006). 
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PRRs recognize the molecules of the pathogen, also called pathogen associated molecular 
patterns (PAMPs). Toll-like receptors (TLRs) are specialized types of the PRRs and are located 
at either the cell surface or within the endosome. They are mainly expressed by antigen-
presenting cells, such as macrophage and dendritic cells. Binding of TLRs to PAMPs triggers the 
MyD88-dependent signaling cascade, which induces the activation of transcription factor NF-kB. 
Activated NF-kB diffuses into the cell nucleus and activates transcription of proinflammatory 
cytokines and chemokines, leading to the recruitment of phagocytic cells to the infected site as 
well as initiating the adaptive immune response. T. cruzi has several molecules that activate 
different TLRs, such as the mucin, glycoinositophospholipid (GIPL), and T. cruzi DNA and 
RNA. Mucin is a glycosylphosphatidylinositol (GPI)-anchored surface protein of T. cruzi 
(Almeida and Gazzinelli 2001). It binds and activates TLR2/TLR6, leading to the production of 
cytokines IL-12, TNF, and nitric oxide. GIPLs are free GPI anchors present in all forms of T. 
cruzi; they bind to and activate TLR4, leading to increased cytokine production. IL-12 also 
activates natural killer cells (NK). NK cells are cytotoxic and are able to kill parasite-infected 
cells. NK cells also activate macrophages by inducing production of the cytokine IFN- 
(Gazzinelli and Denkers 2006). 
Unlike TLR2/TLR6 and TLR4, TLR7 and TLR9 are located on the intracellular 
membrane of endosomes and are activated by binding T. cruzi DNA and/or RNA molecules. 
Activation of TLR7 and TLR9 stimulates the production of Th1 proinflammatory cytokines 
(Cardoso et al. 2016). Nucleotide-binding oligomerization domain (Nod)-like receptors (NLR) 
are another type of PRRs and located in the cytoplasm of the cell. Studies show that NLRs are 
involved in controlling T. cruzi infection. However, the mechanism of NLRs is still unknown 
(Cardoso et al. 2016). 
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Complement system and T. cruzi infection 
As the infected cell bursts, T. cruzi parasites enter the blood stream and encounter the 
complement system of the innate immune response. The complement system consists of three 
pathways: classical, alternative, and lectin. All pathways produce C3 convertase and C5 
convertase, which lead to formation of the membrane attack complex (MAC). MAC forms pores 
in the lipid bilayer and lyses the parasites. The lectin pathway is activated by binding of mannan-
binding lectin (MBL), H-ficolin, and L-ficolin to the surface of T. cruzi, and is responsible for 
approximately 70% of parasite lysis (Cestari et al. 2009; Cestari and Ramirez 2010; Cestari et al. 
2013). The alternative pathway is activated by spontaneous cleavage of C3 to C3a and C3b 
(Cestari and Ramirez 2010). Anti-T. cruzi antibody is produced by immune cells and binds to the 
surface proteins of T. cruzi. This antibody then binds the C1 molecule and activates the classical 
pathway. To overcome defensive mechanisms of complement pathways, T. cruzi possess a group 
of molecules that prevent the activation of these pathways. For instance, calreticulin, a T. cruzi 
surface protein, interacts with several molecules of the lectin and classical pathways to prevent 
the formation of C3 and C5 convertases (Ferreira et al. 2004). T. cruzi complement regulatory 
protein (CRP), also known as GPI-anchored surface protein, binds to molecules involved in the 
initial steps of the classical and alternative pathways to render them inactive (Norris et al. 1991; 
Norris 1998). T. cruzi transmembrane protein, known as complement C2 receptor inhibition 
trispanning (CRIT), blocks the formation of C3 convertase in the lectin and classical pathways 
(Cestari et al. 2008; Cestari et al. 2009). In summary, T cruzi has diverse molecules that can 
disrupt the complement system, preventing the formation of C3 convertase, a key factor to 
parasite lysis. In addition, C3b molecule is produced by C3 convertase and is an opsonin, which 
enhances the phagocytosis of pathogens. Without C3 convertase, C3b molecule is not formed 
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and therefore prevents the phaygocytosis or lysis of T. cruzi. In addition, a study shows that T. 
cruzi triggers the release of host plasma membrane-derived vesicles, which inhibit the initial 
steps of classical and lectin pathways and facilitates the invasion of T. cruzi (Cestari et al. 2012). 
Adaptive immunity against T. cruzi infection and immunodominance 
Activation of TLRs not only activates the production of cytokines but also bridges the 
innate and adaptive immune responses. One of the hallmarks of an immunological response of 
adaptive immunity against T. cruzi infection is a strong and persistent T helper 1 (Th1) response 
as well as activating CD8+ T cells. Th1 response is dependent on the TL7/TL9 activation 
(Junqueira et al. 2010). Activated Th1 cells produce IFN- which activate macrophages and B 
cells, whose function is to produce specific antibodies for T. cruzi lysis and opsonization. T. 
cruzi also induces the production of IL-10, which triggers T helper 2 response. The cytokine IL-
10 is known to inhibit the activation of Th1 immune response; therefore, activation of IL-10 is 
crucial for parasite survival (Geiger et al. 2016). In addition, the presence of T.cruzi causes 
intense polyclonal B cell activation, which is not specific for parasite antigens, and therefore may 
delay a parasite-specific humoral response (Cardoso et al. 2016). 
 In the infected cell, T. cruzi antigens are released in the cytosol, either from the parasite 
shedding or parasite lysis, will become available for processing and presentation by the major 
histocompatibility complex (MHC) class I. Although, CD8+ T cells could potentially bind many 
T. cruzi antigens, they appear to preferentially recognize only a few T. cruzi epitopes, a process 
called immunodominance (Junqueira et al. 2010). Due to their abundance and high affinity to 
MHC and T cell receptor, the trans-sialidase and amastigote surface proteins are two important 
immunodominant antigens during T. cruzi infection (Junqueira et al. 2010; Cardoso et al. 2016). 
Studies suggest that immunodominance interferes with a broad recognition of T.cruzi antigens, 
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rendering the immune response unable to eradicate T. cruzi and leading to persistent infection 
and subsequent chronic Chagas disease (Rodrigues et al. 2009). 
Epidemiology 
There are two main transmission cycles of Chagas disease: wild (sylvatic) transmission 
cycle, occurring in wild kissing bugs and wild animals, and domestic transmission cycle, 
occurring in humans and household animals if kissing bugs live in human dwellings (home-
dwelling kissing bugs). Peridomestic cycle is originated from both domestic and wild cycles, 
maintained by wild kissing bugs and domestic animals and occurs in areas surrounding human 
dwellings (Coura and Dias 2009). Chagas disease mainly occurs in developing countries with 
substandard rural housing and new urban or peri-urban areas, which allow infestation with the 
kissing bugs. Those infected often live in homes with mud walls and/or thatched roofing. If the 
kissing bugs inhabit the thatch roof, their feces may rain on the household items and food. 
There are more than 180 wild mammalian species known to serve as T. cruzi reservoirs, 
including marsupials, xenarthra, bats, carnivores, lagomorphs, rodents, and non-human primates 
(Coura and Dias 2009). Domestic reservoirs are primarily dogs, cats, rats, mice, and cattle. 
Others animals, such as birds, reptiles, and fish could provide a blood meal for triatomine 
vectors. However, only mammals are known to support T. cruzi infection. The parasite’s ability 
to survive in mammals is due in part to its expression of complement inhibitors that subvert 
innate immunity (Tambourgi et al. 1993; Norris 1998; Atayde et al. 2004; Cestari et al. 2008).  
Vectors of T. cruzi are from the Reduviidae family (or subfamily Triatominae), mainly 
from the genera Triatoma, Rohdnius and Panstrongylus, with T. infestans, T. dimidiata, R. 
proxilus, and P. megistus being the most important vectors (Rassi et al. 2010; Carabarin-Lima et 
al. 2013). Most species are found from southern Argentina up to 40º North latitude in the United 
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States and from sea level up to 1500 meters of altitude (WHO 2002). Triatomines are nocturnal, 
have 5 nymphal stages, and adults of two sexes. They rely on blood exclusively for development 
and egg production. The probability of triatomines infected with T. cruzi is proportional to the 
number of blood meal taken. Therefore, older triatomines tend to have higher chances of having 
T. cruzi infection (Rassi et al. 2010). T. infestans is almost exclusively associated with human 
dwellings and is the main vector in the southern cone of South America, such as Uruguay, Chile, 
Brazil, and Argentina (WHO 2002; Vazquez-Prokopec et al. 2009; Rassi et al. 2010). R. proxilus 
is mainly found in Central America and northern South America (Rassi et al. 2010). Distribution 
of T. dimidiata is similar to R. proxilus but also extends to North America, including Mexico 
(Rassi et al. 2010). P. megistus is reported in South America and is the most important Chagas 
disease vector in Brazil (WHO 2002; Ribeiro et al. 2015).  
Vector-borne transmission is the predominant route of infection with T. cruzi. However, 
organ transplantation, blood transfusion, ingestion of infected kissing bugs, T. cruzi–
contaminated foods/liquids, and working in laboratories with live T. cruzi, are also potential 
routes of infection (Rassi et al. 2010). The infection can also occur congenitally via placenta and 
in ingestion of breast milk of an infected mother (Rassi et al. 2010; Steverding 2014). 
Furthermore, research demonstrating T. cruzi in gonads of mice suggests that Chagas disease 
could potentially be transmitted through sexual intercourse (Carvalho et al. 2009). 
Even though Chagas disease is a major public health problem in endemic countries, little 
is known of the distribution of this disease in non-endemic areas. Chagas disease has been 
increasingly detected in the USA, Canada, and many European and Asian countries, due mainly 
to migration between Latin America and the rest of the world. Based on the immigration rate 
from Latin America to the USA and the prevalence of the disease, it is estimated that more than 
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300,000 individuals in the USA are infected with T. cruzi and more than half originated from 
Mexico. Since blood donation screening for T. cruzi started in 2009, 2,183 cases have been 
detected with T. cruzi infection in all states of the US except Wyoming and South Dakota (2016). 
In non-endemic areas, the main transmission mode is through transplantation, blood transfusion, 
and birth. 
Diagnosis 
Diagnosis of Chagas infection is accomplished with several different methods, which are 
used according to the phases of Chagas infection. During the acute phase, the parasitemia 
(circulating trypomastigotes in blood) is high and is easily detected in an anticoagulated blood or 
buffy coat by microscopic examination (Bern et al. 2007; Messenger et al. 2015). 
Trypomastigotes in blood are also visualized by staining with Giemsa or other stains and can be 
grown in specialized media in the laboratory (Bern 2015). Parasitemias decreases 2-3 months 
after infection, even without treatment, so microscopic examination is not accurate for patients 
with chronic infection. Since T. cruzi can be transmitted from chronically infected patients 
(blood transfusion, organ transplantation, and congenital infection) due to undetected infections, 
accurate diagnosis is critical (Bern 2015). Polymerase chain reaction (PCR) is a very sensitive 
diagnostic tool for the acute phase, congenital infection, and for recipients of an infected organ 
(Bern et al. 2011).  
During the chronic phase, several serological tests are used to detect the presence of IgG 
antibodies against T. cruzi antigens, such as enzyme-linked immunosorbent assay (ELISA) or 
indirect and direct immunofluorescent antibody assays (IFA) (Bern 2015). Two serological tests 
are often required for a conclusive result. When results are different, a third test is used to 
confirm or disprove the diagnosis. Assays used as reference tests do not have high sensitivity and 
 17 
 
accuracy for diagnosis, including radioimmunoprecipitation assay (RIPA) and trypomastigote 
excreted-secreted antigen immunoblot (TESA-blot) (Bern et al. 2011). Studies show that 
different T. cruzi strains possibly affect the sensitivity of serological tests (Bern et al. 2011). 
Treatment and Control 
 There are two treatment options for Chagas disease: antitrypanosomal and symptomatic 
treatments (Bern et al. 2007). Antitrypanosomal treatment seeks to eradicate the parasites living 
in the patient’s tissues. Benznidazole and nifurtimox are widely used as anti-parasitic drugs and 
are recommended for acute, congenital, and reactivated infections in individuals who have 
become immune-suppressed (Bern et al. 2011). These are offered to patients with chronic 
infections at the age of 18 or older (Bern et al. 2007). In the 1990s, studies found that 
benznidazole show 60% efficacy in chronic Chagas disease patients in treatment trials (de 
Andrade et al. 1996; Estani et al. 1998). Studies also show that benznidazole treatment prevents 
the progression of cardiomyopathy and decreases mortality in chronically infected adults (Viotti 
et al. 1994; Viotti et al. 2006). 
Symptomatic treatment does not involve killing parasites, but lessening the cardiac and 
digestive manifestations that occur later in the chronic phase. For cardiac symptoms, single or 
several treatments may be used to prevent further complications, including medications, 
pacemaker, devices to regulate heart rhythm, or surgery (Rassi et al. 2010). Amiodarone has 
been widely used for patients with irregular heart rhythm and myocardial dysfunction. In severe 
cases, implantable cardioverter defilbrillators (ICDs) are also used. Patients with 
bradyarrhythmia (slow heart rate) are treated with medication and/or pacemaker. Treatment of 
gastrointestinal symptoms may include medication, diet, corticosteroids, or surgery (Rassi et al. 
2010). Patients with megaoesophagus would have food and liquid deposited directly to the 
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stomach; in severe cases, esophagectomy is used. An early stage of colonic symptom can be 
treated with rich-fiber diet and abundant fluid intake, laxative, or enema. Patients with severe 
cases will undergo surgical organ resection. 
 A vaccine has not been developed for Chagas disease. The main focus of prevention is 
through vector control and prevention of non-vector borne transmission (Rassi et al. 2010). 
Application of insecticide is extensively used in triatomine-infested houses and endemic regions, 
as well as house improvement and health education. Screening of blood donors prevents T. cruzi 
transmission through organ transplantation and blood transfusion. 
Genetic Diversity of T. cruzi 
 Trypanosoma cruzi is believed to have spread throughout the Americas by bats and is a 
clonal species, dividing by binary fission (Steverding 2014). This parasite was classified into two 
major lineages, T. cruzi I (TCI) and T. cruzi II (TCII). TCII has been further subdivided into five 
groups: IIa, IIb, IIc, IId, and IIe (Zingales et al. 2009). Recently, the lineages have been revised 
and classified into seven discrete typing units (DTUs), namely TcI (TCI), TcII (IIb), TcIII (IIc), 
TcIV (IIa), TcV (IId), TcVI (IIe), and the most recently proposed Tcbat (Marcili et al. 2009; 
Zingales et al. 2012). TcV and TcVI are hybrids of TcII and TcIII (Machado and Ayala 2001; 
Westenberger et al. 2005; De Freitas et al. 2006; Lewis et al. 2011). These hybrids may have 
arisen from two independent recombination events or a single incidence of hybridization 
followed by clonal divergence (Lewis et al. 2011). Tcbat, considered to be a bat-exclusive 
lineage of T. cruzi, has not been reported north of Panama (Breniere et al. 2016). Tcbatw is 
closely related to TcI and can be mistaken for TcI using standard molecular identification (Lima 
et al. 2015). It has been suggested that different DTUs cause different disease pathology of 
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Chagas disease, but it is unknown if there is an association between parasite DTUs and clinical 
manifestations (Rassi et al. 2010).  
 There are four proposed subgroups within the TcI DTU, known as haplotypes Ia, Ib, Ic, 
and Id (Herrera et al. 2009). Research suggests that haplotype Ia is associated with the domestic 
cycle and the vector R. proxilus, haplotype Ib is associated with humans, the peridomestic cycle, 
the vector T. dimidiata, haplotype Ic is associated with the peridomestic cycle, and haplotype Id 
is associated with the sylvatic transmission cycle (Herrera et al. 2009). A recent study reported 
that TcIa was has been found in three different states in Mexico, including in T. dimidiata in the 
Yucatan Penisula, in T. (Meccus) picturatus in Nayarit, and in an acute human case in Oaxaca 
(Monteón et al. 2014). Several studies have observed TcI circulating in vectors in Jalisco. 
However, haplotypes of TcI have not been previously identified (Magallón-Gastélum et al. 2004; 
Magallón-Gastélum et al. 2006; Brenière et al. 2007; Brenière et al. 2010) 
Distribution of T. cruzi DTUs 
The distribution of DTUs is distinct in North, Central, and South America (Fig. 3). TcI is 
the dominant strain (60% of the overall identifications) and frequently observed in sylvatic 
cycles but also in the domestic cycle throughout the Americas (Brenière et al. 2016). TcI and 
TcIV are the only DTUs reported in Central America (Higo et al. 2004; Ruíz-Sánchez et al. 
2005; Iwagami et al. 2007; Brenière et al. 2016). In contrast, all DTUs have been detected in 
South America (Brenière et al. 2016). In the southern cone, TcII, TcV, and TcVI were proposed 
as the main agents of T. cruzi infection in domicilary transmission, whereas TcIII and TcIV were 
only occasionally found in humans (Brenière et al. 2016). In North America, all DTUs have been 
detected except TcVI and Tcbat (Brenière et al. 2016). 
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Fig. 3. Distribution of T. cruzi DTUs in North, Central, and South America (Brenière et al. 2016) 
  
 21 
 
CHAPTER III 
HIGH DIVERSITY OF TRYPANOSOMA CRUZI DISCRETE TYPING UNITS 
CIRCULATING IN TRIATOMA IN WESTERN MEXICO 
Uyen T. Nguyen 
Department of Biological Science, Central Washington University, 400 E Ellensburg, WA 
98926, USA 
 
Daniel D. Beck 
Department of Biological Science, Central Washington University, 400 E Ellensburg, WA 
98926, USA 
 
Analiese M. Wenger 
Department of Biological Science, Central Washington University, 400 E Ellensburg, WA 
98926, USA 
 
Víctor Sánchez-Cordero 
Instituto de Biología, Universidad Nacional Autónoma de México, México D.F., México 
 
Angel Rodriguez-Moreno 
Instituto de Biología, Universidad Nacional Autónoma de México, México D.F., México 
 
Gabrielle A. Stryker 
Department of Biological Science, Central Washington University, 400 E Ellensburg, WA 
98926, USA 
Abstract 
Chagas disease is caused by the protozoan parasite Trypanosoma cruzi, which is 
transmitted to domestic and sylvatic mammals via the feces of hematophagous hemiptera of the 
subfamily Triatominae (Reduviidae). Trypanosoma cruzi is found only in the Americas and 
displays remarkable genetic diversity. Seven discrete typing units (DTUs) are currently 
recognized (TcI–TcVI and TcBat). In Jalisco, Mexico, where Chagas disease has a high 
prevalence rate, TcI has historically been the only DTU reported. This study focused on the 
molecular identification of T. cruzi DTUs circulating in Triatoma near the Estación de 
Biología Chamela, on the southwest coast of Jalisco, Mexico. We collected DNA from 95 
Triatoma bugs. Trypanosoma cruzi infection was detected using PCR primers specific for the 
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minicircle variable region of the parasite’s kinetoplast DNA (kDNA). Trypanosoma cruzi DTUs 
were identified by amplifying the intergenic region of the mini-exon, and the genes 24Sα, 18S, 
TcSC5D, and TcMK. Two species of Triatoma were collected, Triatoma longipennis and T. 
bolivari, with an overall infection rate of 59%. There was high genetic diversity of T. cruzi in our 
samples, with the DTUs TcI, TcII, TcIV, TcVI, and Tcbat being identified. This is the first report 
of TcVI and Tcbat in North America. In the Triatoma found to be infected, 96% had TcI, 35% 
TcII, 2% TcIV, 25% TcVI, and 2% Tcbat. Several vertebrate hosts for Triatoma were also 
identified from visible blood within Triatominaes’ gut using PCR primers for cytochrome b and 
cytochrome oxidase subunit I genes. Our observations indicate a much higher diversity of T. 
cruzi DTUs in Triatoma than previously reported in Jalisco. The results have important 
implications for understanding the geographical distribution of T. cruzi DTUs and epidemiology 
of Chagas disease in Mexico.  
Keywords: Trypanosoma cruzi, Genotyping, Discrete typing units (DTUs), Triatoma 
longipennis, Triatoma bolivari, Seasonally dry tropical forest, Jalisco, Mexico 
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Introduction 
Chagas disease (American trypanosomiasis) is caused by infection with Trypanosoma 
cruzi, a parasitic protozoan found in over 180 species of mammals wherever Triatominae insect 
vectors are found, between approximately 40o N and S of the equator in the Americas ("Who, 
how, what and where ?" 2010). Chagas disease is responsible for disability and early death in 
approximately one-third of those infected (Carabarin-Lima et al. 2013). The WHO reports that 
approximately 5-6 million individuals are infected with Chagas disease, more than 25 million at 
risk, and 10,000 die each year in endemic areas (WHO 2010; 2015). Chagas disease has been 
increasingly detected in the US, Canada, and many European and Asian countries due to human 
migration between Latin America and the rest of the world (Coura and Viñas 2010). Although 
the vector does not live outside of the Americas, the risk of blood-borne transmission and burden 
of health care for those with chronic Chagas disease makes T. cruzi a global threat to public 
health.  
In Mexico, it is estimated that 1.1 to 2 million people are infected with Chagas disease, 
predominately through vector-borne exposure (Carabarin-Lima et al. 2013). Human infections in 
Mexico come from both domestic and sylvatic transmission (Carabarin-Lima et al. 2013). 
Trypanosoma cruzi infection has also increasingly been transmitted via blood transfusion 
(Carabarin-Lima et al. 2013), although mandatory serological screening nationwide is reducing 
this risk (Sánchez-González et al. 2016). In addition, there is no consensus on diagnostic 
methods and trypanocidal treatment is not administered to chronic patients (Carabarin-Lima et 
al. 2013). The disease is also becoming more urbanized likely due to human migration from rural 
areas to Mexican cities, mostly in search of jobs (Carabarin-Lima et al. 2013). There are 18 
regions in Mexico, all rural, that have endemic T. cruzi transmission, including the states of 
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Oaxaca, Jalisco, Yucatan, Chiapas, Veracruz, Puebla, Guerrero, Hidalgo, and Morelos 
(Carabarin-Lima et al. 2013).  
The hematophagous triatomine vectors of T. cruzi include several species of the 
subfamily Triatominae (family Reduviidae) in 3 genera (Triatoma, Rhodnius, Panstrongylus). At 
least 31 species of Triatoma have been reported in Mexico with the most important vectors being 
T. barberi, R. prolixus, T. dimidata, T. gerstaekeri, T. longipennis, T. mazzotti, T. mexicana, T. 
pallidipennis, T. phyllosoma, T. picturata, and T. rubida (Ramsey et al. 2015). Control of 
Triatominae vectors in countries where domestic Chagas disease occurs primarily involves 
insecticide treatment of homes to reduce infestation. This has been shown to be the most cost 
effective option to control domestic Chagas disease (Coura and Dias 2009; Vazquez-Prokopec et 
al. 2009; Waleckx et al. 2014). In Mexico, where the majority of transmission is believed to be 
due to transient seasonal infestations from adult Triatoma dispersals from sylvatic habitats to 
human dwellings, the effectiveness of yearly treatment has not been studied (Waleckx et al. 
2014). However, current control programs for mosquitoes to prevent Dengue transmission could 
potentially reduce Triatoma in residential areas (Carabarin-Lima et al. 2013).  
Trypanosoma cruzi was originally assigned to two major lineages, T. cruzi I (TCI) and T. 
cruzi II (TCII). TCII was further subdivided into five groups: IIa, IIb, IIc, IId, and IIe (Zingales 
et al. 2009). Recently, the lineages have been revised and classified into seven discrete typing 
units (DTUs), namely TcI (TCI), TcII (IIb), TcIII (IIc), TcIV (IIa), TcV (IId), TcVI (IIe), and the 
most recently proposed Tcbat (Zingales et al. 2009). TcV and TcVI are hybrids of TcII and TcIII 
(Zingales et al. 2012). These hybrids may have arisen from two independent recombination 
events or a single incidence of hybridization followed by clonal divergence (Lewis et al. 2011). 
It has been suggested that different DTUs cause different disease pathology of Chagas disease, 
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but it is unknown if there is an association between parasite DTUs and clinical manifestations 
(Messenger et al. 2015). 
Within TcI there is additional genetic diversity or haplotypes. The most commonly 
employed method for determining the haplotype of T. cruzi DTUs is based on genetic variability 
of the intergenic region of the mini-exon (Souto et al. 1996). By analyzing the intergenic region 
of the mini-exon, it is possible to determine four subgroups of TcI DTU, known as haplotypes Ia, 
Ib, Ic, and Id (Herrera et al. 2009). TcIa has been found in eastern Mexico but haplotype studies 
have not been undertaken in Jalisco (Monteón et al. 2014). 
The dominant strain of T. cruzi in Mexico is TcI (Bosseno et al. 2002; Brenière et al. 
2007), but recent studies have indicated other DTUs (TcII, III, IV, V) circulating in Triatominaes 
in Veracruz and Michoacán, Mexico (Ramos-Ligonio et al. 2012; Ibáñez-Cervantes et al. 2013). 
One study also reported many patients in Mexico were seropositive for TCII, which includes 
DTUs TcII-VI (Risso et al. 2011). These studies suggest either that the diversity of T. cruzi 
strains in Mexico is growing, or increased sampling has led to a better understanding of the 
complexity of DTUs within Mexico. Jalisco has the highest prevalence of T. cruzi infection in 
Mexico, as 12% of the population was found to be seropositive (Carabarin-Lima et al. 2013), and 
only TcI has been previously reported there (Bosseno et al. 2002; Brenière et al. 2007). 
However, Jalisco is adjacent to Michoacán, where multiple T. cruzi DTUs have been identified 
(Ibáñez-Cervantes et al. 2013). Given these findings, Jalisco could potentially have greater 
diversity of T. cruzi DTUs than previously reported. A recent survey showed that Jalisco is one 
of 10 Mexican states that have greatest risk for human exposure to infected Triatominae (Ramsey 
et al. 2015).  
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Our study explores the prevalence and diversity of potential T. cruzi DTUs within their 
sylvatic Triatoma insect vectors inhabiting a tropical dry forest reserve in coastal Jalisco, 
Mexico. Our objectives were to (a) evaluate the prevalence of T. cruzi in the local Triatominae, 
(b) determine the T. cruzi DTUs and haplotypes present in the region, (c) identify Triatominae 
vectors encountered near Estación de Biología Chamela (EBCh) in Jalisco, Mexico, and (d) 
when possible, determine which vertebrates are serving as hosts for Triatominae.  
Materials and Methods 
Study site  
The Estación de Biología, Chamela (EBCh) is an ecological reserve and research station 
located in Jalisco in western Mexico (19º30'N, 105º03'W). The field station, owned and managed 
by the Universidad Nacional Autónoma de México (UNAM), is situated on 3,319 ha of 
undisturbed seasonally dry tropical forest (SDTF) and surrounding by an additional 13,142 ha of 
forest comprising the Chamela-Cuixmala Biosphere Reserve, one of few SDTFs protected areas 
on the planet (Ceballos 1995; Dirzo et al. 2011). The climate is highly seasonal, characterized by 
a pronounced dry season (Nov – Jun) and a 4-mo wet season (Jul – Oct) during which 80% of 
annual precipitation falls (Bullock 1986). From 1978 to 2015, mean annual precipitation was 
829mm (range 300 – 1,300 mm; UNAM, EBCh meteorological data archives).  
Collection and identification of triatomines  
A total of 95 specimens were analyzed in this study. Triatoma were collected at three 
different periods during 2014- 2015 at EBCh. Eighteen Triatoma in our sample were captured in 
pitfall traps, initially installed in the Chamela forest for capturing lizards (García and Cabrera 
Reyes 2008), but which also proved to be useful in trapping Triatoma in this study. Several 
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Triatominaes were also collected by hand at EBCh due to their attraction to light (lit buildings 
and windows). All insects were euthanized by placing in -20ºC freezer for one hour.  
Extraction of Triatoma DNA 
Triatomines’ hindgut contents were placed on FTATM cards (GE Healthcare) to render 
any parasites non-infectious and to preserve DNA samples (Rogers and Burgoyne 1997; Kraus et 
al. 2011). Triatomines that were previously stored in 100% ethanol or dried were processed by 
macerating the abdomen in 500 µl distilled water followed by three cycles of freezing at -20ºC 
and thawing at room temperature before placing the mixture onto FTATM card. For a 25 l PCR 
reaction mixture, a 2 mm disc of the FTA card was cut out using Disposable Biopsy Punches, 
Integra™ Miltex® (Integra LifeScience). Prior to PCR, FTA discs were washed with FTA 
Purification Reagent (GE Healthcare) according to the manufacturer’s instruction.  
Diagnostic PCR 
In this study, all amplification products were generated in a 25 l reaction mixture 
containing a 2mm FTA disc, 0.2 M of each primer, 12.5 µl of Apex Taq RED Master Mix 
(Genesee Scientific) and Nanopure™ Ultrapure H2O, and generated in a C1000TM Thermal 
Cycler (Bio-Rad). All amplification products were separated on either TAE or TBE-agarose gel 
(Agarose GP2, MidsciTM) with ethidium bromide and were visualized under UV light. Negative 
and positive controls (CL Brener, ATCC®) were carried out for all DNA samples. 
Since Triatominae can be infected with either T. cruzi and/or Trypanosoma rangeli, all 
samples were subjected to PCR analysis using the primers TE and TR which are specific for T. 
rangeli (Fernandes et al. 2001) and amplify a 100 bp mini-exon PCR product (Table 1). 
Amplification products were separated on 2% TAE-agarose gel. To detect T.cruzi DNA, a 
diagnostic PCR was performed on all samples by amplifying the minicircle variable region of the 
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kinetoplast DNA (kDNA) using primers 121 and 122 (Table 1) (Cardoso et al. 1994). Samples 
that showed the diagnostic 330 bp fragment were considered T. cruzi-positive and were selected 
for molecular identification of T. cruzi DTUs.  
Table 1 Primers, annealing temperature, and amplicon size used for identification of T.cruzi DTUs, 
triatomines, and blood meal source 
Target 
organism 
Target gene Primer name 5’-3’ Primer sequence Anneal 
ºC 
Amplicon 
size 
Ref. 
T. rangeli Non-transcribed 
spacer region of 
mini-exon 
TR 
TE 
CCT ATT GTG ATC CCC ATC TTC G 
TAC CAA TAT AGT ACA GAA ACT G 
50 100 bp (Fernandes et 
al. 2001) 
T. cruzi Variable region 
of mini-exon  
121 
122 
AAA TAA TGT ACG GGK GAG ATG CAT GA 
GGT TCG ATT GGG GTT GGT GTA ATA TA 
57 330 bp (Cardoso et 
al. 1994) 
T. cruzi Intergenic 
region of mini-
exon 
TC1 
TC2 
TC 
GTG TCC GCC ACC TCC TTC GGG CC 
CCT GCA GGC ACA CGT GTG TGT G 
CCC CCC TCC CAG GCC ACA CTG 
55 see table 2 (Souto et al. 
1996) 
T. cruzi TcSC5D TcSC5D-fwd 
TcSC5D-rev 
GGA CGT GGC GTT TGA TTT AT 
TCC CAT CTT CTT CGT TGA CT 
58 832 bp (Cosentino 
and Agüero 
2012) 
T. cruzi TcMK Tc-Mev-
kinase26-Fw 
Tc-Meb-
kinase662-Rv 
TTT TTG CAT GTC ATT TTG G 
AGC GGT CTT GTA ATG AGC AC 
58 637 bp (Cosentino 
and Agüero 
2012) 
T. cruzi 24Sα  D71 
D72 
AAG GTG CGC GAC AGT GTG G 
TTT TCA GAA TGG CCG AAC AGT 
60 see table 2 (Souto and 
Zingales 
1993) 
T. cruzi 18S  V1 
V2 
CAA GCG GCT GGG TGG TTA TTC CA 
TTG AGG GAA GGC ATG ACA CAT GT 
60 see table 2 (Clark and 
Pung 1994) 
Vertebrate 
Triatoma sp. 
mtDNA cyt b Forward-cytb 
Reverse-cytb 
GAG GMC AAA TAT CAT TCT GAG G 
TAG GGC VAG GAC TCC TCC TAG T 
50 457 bp (Mehus et al. 
2013) 
Vertebrate mtDNA COI Forward- 
COI_long 
Reverse- 
COI_long 
AAC CAC AAA GAC ATT GGC AC 
AAG AAT CAG AAT ARG TGT T 
50 663 bp (Mehus et al. 
2013) 
Triatoma sp. mtDNA COI LCO1490 
HCO2198 
GGT CAA CAA ATC ATA AAG ATA TTG G 
TAA ACT TCA GGG TGA CCA AAA AAT CA 
50 710 bp (Folmer et 
al. 1994) 
 
Molecular identification of T. cruzi DTUs 
Trypanosoma cruzi genotyping was accomplished using two different methods. In the 
first method, we analyzed three gene fragments of T. cruzi: the intergenic region of the mini-
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exon, and the genes 24Sα and 18S. Table 2 summarizes the expected size of amplification 
products. In the second method, we targeted the gene fragments of TcSC5D (putative 
lathosterol/episterol oxidase) and TcMK (mevalonate kinase) of T. cruzi (Cosentino and Agüero 
2012).  
Table 2 PCR amplification scheme and expected DNA fragments of different T. cruzi DTUs 
 TcI TcII TcIII TcIV TcV TcVI 
Mini exon (TC, TC1 and TC2 primers) 350 300 - - 300 300 
24Sα rRNA (D71 and D72 primers) 110 125 110 120,125,130* 100, 125 125 
18S rRNA (V1 and V2 primers) 175 165 165 155 155 - 
*TcIV could have either 120, 125 or 130 bp (Brisse et al. 2001; Ramos-Ligonio et al. 2012) 
PCR amplification of the mini exon intergenic region: Multiplex PCR, using the primer 
set TC1, TC2 and TC, was used to amplify the mini-exon intergenic region (Souto et al. 1996). 
Amplification products were separated on 2% TAE-agarose gel. PCR amplification produced a 
350bp fragment for TcI and/or 300bp for DTUs TcII, TcV, and TcVI. 
PCR amplification of the 24Sα: DTUs TcII, TcV, and TcVI were detected by 
amplification of 24Sα rRNA using primers D71 and D72 (Souto and Zingales 1993). 
Amplification products were separated by on 3% TAE-agarose gel due to small amplicon size. 
24Sα PCR amplified 125 bp fragment from TcII, 110 bp fragment from TcIII, 120, 125, and 130 
bp fragments from TcIV, 110 and 125 bp fragments from TcV, and 125 bp fragment is produced 
from TcVI (Table 2). 
PCR amplification of the 18S: DTUs TcIII and TcIV both produce a 125 bp 24Sα PCR 
product, therefore the DTUs were distinguished by amplification of the gene encoding 18S rRNA 
using the primers V1 and V2 (Clark and Pung 1994). Amplification products were separated on 
3% TAE-agarose gel. 18S PCR amplified a 165 bp fragment from TcII, and no fragment is 
produced from TcVI (Table 2). 
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DTU determination using the TcSC5D and TcMK genes: Cosentino and Agüero (2012) 
proposed a simple typing assay for determining T. cruzi DTUs that requires a single PCR 
amplification followed by either restriction enzyme digest or a direct sequencing assay. 
Amplification protocols for TcSC5D and TcMK were carried out according to the published 
protocol (Cosentino and Agüero 2012). TcSC5D gene fragments were used to determine DTUs 
TcI, TcII, TcIII, TcIV and Tcbat. TcMK fragments were used to determine TcV and TcVI. PCR 
was followed by enzyme digestion as described by Cosentino and Aguero (2012). Prior to 
enzyme digestion, PCR products were purified using DNA Clean & Concentrator-5 Kit (Genesee 
Scientific). A sample of 20 µl of purified TcSC5D PCR products were digested with 1 U of HpaI 
(NEB R0105) and 1 U SphI (NEB R0182) at 37ºC for 1 h. Digestions were performed in the 
CutSmart buffer (NEB B7204S). The digested fragments were resolved in 2% TBE-agarose gels. 
For TcMK gene, 20 µl of the purified TcMK PCR products were digested with 1 U of XhoI (NEB 
R0146) at 37ºC for 1 h. The digested fragments were resolved in 2.5% TBE-agarose gels. 
Identification of Triatominaes 
Identification of Triatoma found at EBCh involved using a dichotomous key (Lent and 
Wygodzinsky 1979), comparison to specimens deposited in the national collection of insects in 
the Institute of Biology, UNAM, and PCR analysis targeting a 457 bp region of mitochondrial 
cytochrome b (cyt b) and a 710 bp region of the cytochrome oxidase subunit I (COI) genes 
followed by sequencing (Table 1) (Folmer et al. 1994; Mehus et al. 2013). Two reference 
samples of T. longipennis, male and female, were sent to UNAM for identification due to 
difficulty with visual identification (Fig. 4).  
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Fig. 4. Triatoma collected at Estación de Biología, Chamela. a. Triatoma bolivari, male, 
24.4mm in length, collected on July 5, 2015 outside the library at EBCh, b. Triatoma 
longipennis, female, 35.5mm in length, collected on July 7, 2015 in a pitfall trap near Arroyo 
Colorado in the Chamela-Cuixmala Biosphere Reserve, c. close-up of T. longipennis head, 
corium, and pronotum, d. close-up of T. longipennis head and neck demonstrating yellow 
markings on side of neck (arrow) 
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The COI and cyt b genes of Triatominaes were PCR amplified, separated on 2% TAE-
agarose gel, and the corresponding PCR products were purified and submitted for sequencing. 
The sequences were analyzed using the Basic Local Alignment Search Tool (BLAST) at 
National Center for Biotechnology Information (NCBI, https://blast.ncbi.nlm.nih.gov/) to 
identify similarity to Triatoma sequences. 
Identification of Triatoma blood meals 
To identify the origin of Triatoma blood meals, 12 samples containing bllod were 
subjected to PCR analysis by targeting 457 bp region of cyt b genes, and a 663 bp region of the 
COI gene (Table 1) (Mehus et al. 2013). Amplification products were separated on 1.5% TAE-
agarose gel, sequenced, and compared with deposited sequences in Genbank. 
DNA Sequencing  
The PCR products of the mini-exon intergenic region, 24Sα, 18S, TcSC5D, TcMK, cyt b 
and COI genes were excised and recovered from agarose using Zymoclean Gel DNA Recovery 
Kit (Genesee Scientific). The purified PCR products were sequenced by Genewiz, Inc (South 
Plainfield, NJ) and GenScript, Inc (Piscataway, NJ) using ABI 3730 DNA Analyzer. DNA 
sequences were manually aligned using BLAST, edited using BioEdit software and compared 
with the sequences in GenBank using BLAST search to identify the parasite DTUs, Triatoma 
and blood meals sources. 
Results 
T. cruzi detection in Triatoma specimens 
Ninety-five adult triatomines were collected at EBCh or nearby areas in Jalisco, Mexico. 
While collection efforts were attempted in the towns of Chamela and Emiliano Zapata no 
Triatoma were found. This may be due to recent spraying for Dengue in both villages, or the 
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non-domestication of local Triatoma. Two different species of Triatoma (Fig. 4) were found near 
the biological station, 61 T. bolivari (10 females and 51 males) and 34 T. longipennis (21 
females and 13 males). A majority of the T. bolivari were found near light sources around the 
station, while the T. longipennis were predominately found in the forest.  
The gut contents for all of the Triatoma collected were tested for the presence of 
conserved domains of mini-exon or kinetoplastid minicircle DNA using PCR primers specific for 
either T. cruzi or T. rangeli. Trypanosoma rangeli is non-pathogenic for mammals but causes 
pathology in Triatominae of the genus Rhodnius, and can be confused for T. cruzi when 
immunological test methods are used. T. rangeli are primarily seen in R. prolixus (Hoare 1972; 
Azambuja and Garcia 2005), although T. rangeli has been found in Triatoma in Colombia 
(Marinkelle 1968). None of the samples yielded T. rangeli amplicons of the non-transcribed 
spacer of the mini-exon gene using the primers TR/ME. The mini-exon intergenic region is a 
good target for PCR-based detection as there are over 200 tandem repeats each containing a 
highly conserved 39-nt exon sequence (Campbell et al. 2003). Of the 95 samples in our study, 56 
(59%) were positive for T. cruzi using the 121/122 kinetoplast minicircle PCR primers. Because 
each parasite within an infected bug has thousands of 1.4 kb kinetoplast minicircles, the 
minicircles are an ideal target for T. cruzi detection (Thomas et al. 2007). Of the T. bolivari 
samples, 28 of 61(46%) were positive for T. cruzi and 28 of 34 T. longipennis samples (82%) 
tested positive for the parasite.  
The various T. cruzi DTUs that we identified in our Triatoma samples are shown in     
Fig. 5. To identify T. cruzi, DTUs four different regions were targeted: 1) the mini-exon 
intergenic region, 2) the 24Sα and 18S ribosomal genes, 3) the TcSC5D gene, and 4) the TcMK 
gene. The limited amount of T. cruzi DNA that was preserved in samples on the FTA paper 
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made amplifying single copy genomic DNA difficult. Therefore, multiple methods were 
employed to differentiate DTUs from the 56 positive samples (Tables 3). Thirty of those samples 
revealed a mini-exon intergenic region PCR product of 350 bp and were thus identified as 
infected with only TcI (Table 4). One sample produced a PCR product of 300 bp that 
corresponded to either TcII, TcV, or TcVI. Further analysis using the 24Sα and 18S genes 
produced 125 and 165 bp products respectively identifying DTU TcII (1/56, 2%). One sample 
showed neither a 300 bp nor a 350 bp of the mini-exon gene suggesting TcIII or TcIV. This 
sample produced a 125 bp product of the 24Sα gene and a 155bp product of the 18S gene, 
identifying it as TcIV (1/56, 2%).  
 
Fig. 5 The distribution of T. cruzi DTUs in EBCh Triatoma. Each hatch mark represents an 
individual Triatoma, boxes below the line represent the different DTUs found in each individual. 
A. Out of 34 T. longipennis, 28 (82%) contained T. cruzi DTUs. B. Out of 61 T. bolivari 28 
(46%) contained T. cruzi DTUs 
Twenty-four of the 56 T. cruzi positive samples produced two products of 350 bp and 300 
bp and therefore contained multiple DTUs. These samples with mixed infections of T. cruzi 
DTUs were further analyzed using 24Sα and 18S ribosomal genes; however, most of the PCRs 
produced amplification products of 110bp (24Sα) and 175bp (18S), which demonstrates only TcI 
(Table 2). The amount of TcI DNA might be more abundant in samples with mixed infections, or 
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the primers may preferentially amplify TcI over other DTUs, which would explain why the 24Sα 
and 18S primers tended to pick up only the ribosomal genes from TcI. 
Of the 56 positive samples, 35 amplified with primers TcSC5D-fwd/TcSC5D-rev, which 
target the genomic single copy TcSC5D gene. We were not able to amplify the TcSC5D gene in 
the remaining 31 positive samples because not enough T. cruzi DNA was preserved in the FTA 
paper. Four different DTUs, TcI, TcIV, TcVI, and Tcbat, were found in the 35 samples using the 
TcSC5D gene, a restriction enzyme digestion assay, and DNA sequencing (Table 3 and Table 4). 
The DTUs TcV and TcVI are two independent hybrids that are derived from TcII and TcIII 
(Zingales et al. 2012). Therefore, discrimination of TcV and TcVI by sequencing TcSC5D 
amplification products does not identify the strain. By amplifying a different gene (TcMK) and 
using a restriction enzyme assay we were able to distinguish between TcV and TcVI. 
Considering the data together, 54 of 56 (96%) samples were infected with TcI, 20/56 
(36%) with TcII, 14/56 (25%) with TcVI, 1/56 (2%) with TcIV, and 1/56 (2%) with Tcbat    
(Fig. 5). Many of the infected Triatoma 24/56 (42%) contained mixed DTU populations. 
DNA sequencing and data deposition 
T. cruzi DTU identification was confirmed by sequencing of the mini-exon intergenic 
region, and the TcSC5D and TcMK genes (Table 5). We were able to confirm haplotype TcIa in 
all of the TcI positive samples. Sequence data also confirmed the PCR analysis for TcII, TcIV, 
TcVI, and Tcbat. 
Triatoma bolivari found at EBCh were identified from physical characteristics and by 
sequencing the cyt b gene (Table 6). The cyt b gene of T. bolivari had a 91% identity with the 
only reported cyt b T. bolivari sequence, which was collected at EBCh. There was also a 100% 
identity with the COI gene of a Triatoma sp. deposited in the American Museum of Natural 
36 
 
History, but this specimen had no location or species information. For T. longipennis, the COI 
gene did not have high homology to any deposited sequences and the cyt b gene only had 87% 
identity with a T. longipennis sequence on GenBank (Table 6). 
Table 3 Molecular identification of T. cruzi DTUs and DNA sequencing suggest mixed 
infections in triatomines 
 No of 
samples 
Mini-
exon 
24S and 
18S 
TcSC5D and 
TcMK# 
Total DTUs 
Tl & Tb 11 TcI TcI TcI* TcI 
(n=30) Tl & Tb 19 TcI TcI ND 
T. bolivari 1 TcII TcII TcII** TcII  
(n=1) 
T. longipennis 1 ND TcIV TcIV* TcIV  
(n=1) 
T. bolivari 9 TcI, TcII TcI TcI* TcI, TcII  
(n=10) Tl & Tb 1 TcI, TcII ND ND 
Tl & Tb 3 TcI TcI TcI*, TcVI** TcI, TcVI  
(n=3) T. bolivari 1 TcI - TcVI* 
T. longipennis 2 TcI, TcII TcI TcI*, TcVI** TcI, TcII, TcVI  
(n=9)  7 TcI, TcII - TcI**,TcVI* 
T. longipennis 1 TcI TcI Tcbat*, TcI**, 
TcVI** 
TcI, TcVI, Tcbat  
(n=1) 
*Parasite DTUs were confirmed by both enzyme digestion assay and DNA sequencing results 
**Parasite DTUs were confirmed by enzyme digestion assay only  
# TcMK gene used for TcV and TcVI discrimination 
Tl & Tb = T. longipennis and T. bolivari 
ND = no data was obtained 
 
Table 4 Frequency of T. cruzi DTUs and mixed infections in triatomines 
Triatomines 
Single and mixed infection frequency 
TcI 
only 
TcII 
only 
TcIV 
only 
TcI, 
TcII 
TcI, 
TcVI 
TcI, TcII, 
TcVI 
TcI, TcVI 
Tcbat 
T. longipennis (n=28) 11 - 1 5 1 9 1 
T. bolivari (n=28) 19 1 - 5 3 - - 
Total (n=56) 30 1 1 10 4 9 1 
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Table 5 GenBank accession numbers of TcSC5D, TcMK, and Mini-exon sequences of T. cruzi DTUs  
T. cruzi 
DTUs 
TcSC5D TcMK Mini-exon 
TcI # KX858838* CP015687 (99%) 
JN050565 (99%) 
- - KX858836* AM259467 (TcIa) (99%) 
AM259469 (TcIb) (97%) 
AM259474 (TcIc) (96%) 
AM259473 (TcId) (94%) 
TcII KX987101* JN050574 (99%) 
JN050569 (99%) 
- - KX858837* KM376439 (99%) 
KM376435 (99%) 
TcIV KX858839* JN050564 (99%) 
JN050568 (99%) 
- - - - 
TcVI KX858840* XM_797152 (100%) 
JN050576 (93%) 
KX874594* KR350585 (99%) 
XM_797435 (99%) 
- - 
Tcbat KX858841* TCC1122 (99%) -  - - 
% identity to deposited sequences in GenBank is provided in parenthesis. 
*Sequences were obtained in this study. 
# Haplotype TcIa was identified by DNA sequence of mini-exon. 
Triatoma bolivari found at EBCh were identified from physical characteristics and by 
sequencing the cyt b gene (Table 6). The cyt b gene of T. bolivari had a 91% identity with the 
only reported cyt b T. bolivari sequence, which was collected at EBCh. There was also a 100% 
identity with the COI gene of a Triatoma sp. deposited in the American Museum of Natural 
History, but this specimen had no location or species information. For T. longipennis, the COI 
gene did not have high homology to any deposited sequences and the cyt b gene only had 87% 
identity with a T. longipennis sequence on GenBank (Table 6). 
Table 6 GenBank accession numbers of cyt b and COI sequences of Triatoma.  
Triatoma sp. Cyt b COI 
Triatoma bolivari KY193790* 
JQ282718 
(91% T. bolivari) 
KY033219* 
AY252963 
(100% Triatoma sp.) 
Triatoma longipennis KY033227* 
JN5858554 
(91% T. dimidiata) 
DQ198815 
(87% T. longipennis) 
KY033220* 
KC249392 
(76% T. vandae) 
% identity to deposited sequences in GenBank is provided in parenthesis. 
*Sequences were obtained in this study. 
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Twelve Triatoma had visible blood within their gut contents. The blood meal source was 
identified by amplifying the cyt b and COI genes. The DNA sequences were queried for similar 
sequences using NCBI’s nucleotide BLAST search. Table 7 contains the percent identity of the 
various blood meal sources and their accession numbers. Of the twelve Triatoma containing 
visible blood, we were able to obtain cyt b and COI sequences for eleven samples (Table 7). One 
sample had a low match (81%) for cyt b, but a 100% match for COI of Gallus gallus. One 
sample had 96% match for cyt b of Sciurus aureogaster, but we were not able to compared COI 
sequence of S. aureogaster to other sequences since it is not available on GenBank. 
Table 7 Identification of the triatomines’ blood meals using cyt b and COI genes. 
Triatoma sp. # 
T. cruzi 
DTUs 
Blood meal sources 
Accession # 
Cyt b COI 
T. longipennis 
 
2 TcIa White-tailed deer  
(Odocoileus virginianus) KX874595* KM612275 (99%) KY033224* JN632673 (99%) 1 TcIa, TcII 
1 TcIa Marble toad  
(Incilius (Bufo) marmoreus)  
KX874599* HM563957 (99%) KY033223* JN867979 (99%) 
1 TcIa, TcII Dog (Canis familiaris) KX874598* KU291082 (99%) KY033225* KU696410 (100%) 
1 TcIa, TcII Human (Homo sapiens) 
Dog (Canis familiaris) 
KX874596* 
KX874598* 
AP008916 (100%) 
KU291082 (99%) 
KY033221* 
KY033225* 
KT725864 (100%) 
KU696410 (100%) 
T. bolivari 
 
2 N/A Mexican gray squirrel  
(Sciurus aureogaster)  KX874597* KC737847 (96%) KY033226* - 1 TcIa 
1 TcIa, 
TcVI 
Human (Homo sapiens) 
KX874596* AP008916 (100%) KY033221* KT725864 (100%) 
1 TcIa Chicken (Gallus gallus) KY084833* EF076670 (81%) KY033222* KT780168 (100%) 
% identity to deposited sequences in GenBank is provided in parenthesis. 
*Sequences were obtained in this study. 
 
Discussion 
T. cruzi infection rate at EBCh 
We found many Triatoma infected with T. cruzi within EBCh, with an overall infection 
rate of 59% (82% of T. longipennis and 46% of T. bolivari). Previous studies reported the T. 
cruzi prevalence in Triatoma from Jalisco to range from 46-57%, a result similar to ours 
(Magallón-Gastélum et al. 2004; Brenière et al. 2007; Brenière et al. 2010). The very high 
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infection rate observed in T. longipennis (28/34 or 82%) may be an artifact of small sample size 
and further collection will provide a clearer estimate of the prevalence of T. cruzi in this 
Triatominae. 
High diversity of T. cruzi DTU at EBCh 
The diversity of T. cruzi DTUs has not been thoroughly investigated in Jalisco; only TcI 
has previously been reported (Bosseno et al. 2002; Brenière et al. 2004; Magallón-Gastélum et 
al. 2004; Magallón-Gastélum et al. 2006; Brenière et al. 2007; Walter et al. 2007; Brenière et al. 
2010). Our findings indicate there is greater diversity of T. cruzi DTUs than previously reported. 
This is in agreement with studies from other states in Mexico that indicate high frequencies of 
non-TcI strains. TcIII, TcIV and TcV were observed in Veracruz (12-27% each) (Ramos-Ligonio 
et al. 2012) and TcII, TcIII, and TcIV were found in Michoacán (6-20% each) (Ibáñez-Cervantes 
et al. 2013).  
In our study, TcI, and in particular the haplotype TcIa, was found in 96% of infected 
Triatominae. This result suggests that TcIa is the dominant strain circulating in mammals in 
coastal Jalisco. Several studies have observed TcI circulating in vectors in Jalisco; however, 
haplotypes of TcI have not been previously identified (Magallón-Gastélum et al. 2004; 
Magallón-Gastélum et al. 2006; Brenière et al. 2007; Brenière et al. 2010). Our study confirms 
the presence of the haplotype TcIa in Jalisco. A recent study reported that TcIa was also found in 
three different states in Mexico, including in T. dimidiata in the Yucatan Pennisula, in T. 
(Meccus) picturatus in Nayarit, and in an acute human case in Oaxaca (Monteón et al. 2014). 
The distribution of DTUs is distinct in North, Central, and South America. TcI and TcIV 
are the only DTUs reported in Central America (Brenière et al. 2016). In contrast, all DTUs have 
been detected in South America. In the southern cone, TcII, TcV, and TcVI were proposed as the 
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main agents of T. cruzi infection in domicilary transmission, whereas TcIII and TcIV were only 
occasionally found in humans (2010; Brenière et al. 2016). TcI was frequently observed in 
sylvatic cycles but also in the domestic cycle throughout the Americas (Brenière et al. 2016). In 
North America, all DTUs have been detected, except TcVI and Tcbat (Brenière et al. 2016). 
However, our findings now confirm the presence of TcVI and Tcbat in North America. 
The high diversity of DTUs in a small area could be attributed to human and animal movement. 
It is unknown if the high DTU diversity observed is novel to Mexico, or due to increased 
surveillance. If the non-TcI DTUs are due to migration, visiting scientists at EBCh may be 
contributing to the novel DTUs seen near the biological station. It would be interesting to see if 
sampling other locations in costal Jalisco would yield the same high diversity as in our study at 
EBCh. The high volume of traffic moving along Coastal Mexican Federal Highway 200 
(Carretera Federal 200) through the biological reserve also contributes to the possibility that high 
diversity might be due to migration through the region, complicating understanding of which 
strains are historically found in Jalisco versus imported DTUs. 
First report of DTUs TcVI or Tcbat in North America 
To our knowledge, this is the first report of either TcVI or Tcbat being detected in North 
America (Brenière et al. 2016). TcVI was found in 25% (14/56) of the Triatoma with T. cruzi. 
Because of this relatively high prevalence, our finding suggests that TcVI is likely well 
established in the forest surrounding EBCh. TcVI has been reported throughout South America 
from Argentina to northern Colombia (Messenger et al. 2016). In the southern cone region, TcVI 
is associated with domestic transmission cycles where severe chronic Chagas disease and 
congenital transmission are prevalent (Bern et al. 2011; Messenger et al. 2015). If TcVI is new to 
Mexico, this strain could change the disease dynamics in a country that has enjoyed relatively 
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little chronic Chagas disease despite the abundance of infected Triatoma (Bern et al. 2011; 
Messenger et al. 2015). 
Tcbat, considered to be a bat-exclusive lineage of T. cruzi, has not been reported north of 
Panama (Brenière et al. 2016). Tcbat was described from Brazilian bats showing unique patterns 
of ribosomal and spliced leader PCRs not clustering into any of the other six DTUs (Cavazzana 
et al. 2010; Ramírez et al. 2014; Lima et al. 2015). Tcbat has been reported in bats in from Brazil 
to Panama (Brenière et al. 2016), in a 5 year old girl living in northwestern Columbia (Ramírez 
et al. 2014), and even in mummies from Chile (Guhl et al. 2014). Tcbat is closely related to TcI 
and can be mistaken for TcI using standard molecular identification (Lima et al. 2015). The 
identification technique we used allows us to distinguish Tcbat from other DTUs by targeting a 
single molecular marker, the TcSC5D gene (Cosentino and Agüero 2012). While we only 
encountered one T. longipennis harboring Tcbat, 33 species of bats (7 families) inhabit the 
forests surrounding the field station (Ceballos and Miranda 2000). Given the high diversity of bat 
species in the region, it is not surprising to find Tcbat in our Triatoma sample. There is evidence 
of bat species Glossophaga soricina, Mormoops megalophylla, and Pteronotus parnelli infected 
with T. cruzi in Jalisco (Sánchez-Cordero et al, unpublished). 
Triatoma at EBCh 
We only encountered two species of Triatominae at EBCh, identified as T. bolivari and T. 
longipennis (Figure 1). Several other Triatominae that transmit T. cruzi have been reported in the 
state of Jalisco including T. barberi, T. brailovskyi, T. dimidiata, T. phyllosoma, T. pallidipennis, 
and T. mazzotti (Ramsey et al. 2015). Triatoma are known to have high genetic variability, 
which may be due to their continuous domestication process and fragmentation of habitats 
(Espinoza et al. 2013). 
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The T. bolivari were identified by physical characteristics and the cyt b gene sequence, 
which had a 91% match to a T. bolivari sequence collected at EBCh (Table 6) (Espinoza et al. 
2013). Little work has been done on this Triatoma and few specimens have been collected. The 
initial report of the species, T. bolivari, was from a specimen collected in coastal 
Jalisco (Carcavallo et al. 1987). GeneBank only has 6 sequences reported to be from T. bolivari. 
The only study that has looked at their genetic diversity suggests that there is little diversity 
within this group, which is not consistent with the relatively low 91% identity for cyt b reported 
here (Espinoza et al. 2013). 
Triatoma bolivari has been considered to be of low epidemiological importance (Ramsey 
et al. 2000). However, our study found 46% of T. bolivari infected with T. cruzi and most were 
collected near outdoor lights or inside EBCh buildings. We also identified human blood in a T. 
bolivari found inside the Library at EBCh. Light attraction by triatomines is believed to be a 
potential factor of infestation, which leads to higher chance of T. cruzi infection (Zeledón 1983; 
Rebollar-Téllez et al. 2009). Triatoma bolivari may be a strictly sylvatic species; adults attracted 
by human light sources are unable to colonize buildings. Martinez-Ibarra et al (2010) 
hypothesized that this species may be associated with birds rather than rodents. Our study found 
the predominant blood source in T. bolivari (3 of 5 triatomines with blood present) was the 
Mexican gray squirrel (Sciurus aureogaster). More research is needed to understand potential 
hosts and the role T. bolivari as a vector. However, it appears T. bolivari has disappeared from 
environmentally disturbed areas where it was previously reported and is now confined to coastal 
areas in western Mexico (Ramsey et al. 2000; Martinez-Ibarra et al. 2010). 
Two reference samples of T. longipennis, male and female, were sent to UNAM for 
identification due to physical characteristics not matching reported Triatoma. The COI sequence 
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showed no significant homology to T. longipennis sequences found in GenBank. The highest 
homology was only 76% identity to Triatoma vandae (Table 6), a species from Brazil. We also 
sequenced the cyt b gene and found 87% sequence identity with deposited T. 
longipennis sequences, and 91% identity to T. dimidiata. Morphologically, the species we are 
calling T. longipennis is distinct from T. dimidiata. The Phyllosoma complex species, including 
T. longipennis, are reported to have large genetic variations making it difficult to distinguish 
species using molecular techniques. The relationships are further complicated by the ease of 
hybridization between species. We have called this species T. longipennis due to identification 
by UNAM despite the lack of sequence data to support this identification. 
Blood meal sources  
We targeted the cyt b and COI genes to identify the blood meal source when blood was 
observed in the gut contents of Triatominae. We were able to identify several blood meal sources 
from 11 samples, including Homo sapiens, Odocoileus virginianus, Sciurus aureogaster, Canis 
familiaris, Gallus gallus, and Incilius (Bufo) marmoreus (Table 7). All of these species are found 
in the study area (Myska 2011). Only two of the Triatoma with blood meal source data were 
negative for T. cruzi, both contained Mexican gray squirrel (Sciurus aureogaster) blood.  
Not all of the Triatoma hosts identified through blood meal analysis are potential 
reservoirs of T. cruzi. Over 180 domestic and wild mammals, primarilay marsupials, xenarthras, 
bats, carnivores, lagomorphs, rodents, and primates, serve as hosts for T. cruzi (Carabarin-Lima 
et al. 2013). While many vertebrates can provide a blood meal for Triatoma, only mammals are 
known to support T. cruzi. The ability to survive in mammals is due in part to the parasite’s 
expression of complement inhibitors to subvert innate immunity (Tambourgi et al. 1993; Norris 
1998; Atayde et al. 2004; Cestari et al. 2008). Birds are known to be refractory to T. cruzi 
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infection owing to complement-mediated lysis of the parasite, as T. cruzi’s complement 
inhibitors are mammalian-specific (Kierszenbaum et al. 1981). Therefore, while bird and 
amphibian blood was found in the Triatoma at EBCh, these animals are not contributing to T. 
cruzi transmission. 
FTA paper 
There are many advantages to collecting Triatoma gut contents and preserving the DNA 
on FTA paper. It protects DNA from degradation at room temperature and inactivates pathogens 
for safe handling. However, we found that storing the DNA of Triatominae on FTA paper is not 
optimal for PCR analysis. The amount of T. cruzi DNA retained on the FTA paper was 
considerably less than when DNA was extracted from a whole Triatoma and the distribution of 
DNA on the card was uneven. In addition, genomic DNA of T. cruzi is less abundant than 
kDNA, which made it difficult to amplify genomic sequences from T. cruzi’s 24S, 18S, 
TcSC5D and TcMK genes. In the future, Triatominae samples should be preserved in 70% EtOH 
and whole specimens used for DNA extraction to maximize the DNA sample for analysis. 
Potential risk of T. cruzi infection via wildlife 
The high rates of infection of Triatoma leads to a concern of increased risk for people 
using wildlife as a protein source in the state of Jalisco. If an infected mammal is butchered in 
the field, there is a potential for transmission of the parasite from blood-borne exposure through 
open cuts or from blood spatter on mucus membranes. Little research has been published 
concerning T. cruzi transmission via hunting (Bern et al. 2011). Nevertheless, infection is a real 
risk, especially to those who skin and process wildlife meat themselves (Bern et al. 2011) and to 
those who feed on wildlife inhabiting lowland tropical deciduous forest in the region. Chagas 
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disease should be addressed to the community through public outreach efforts to avoid T. cruzi 
infection. 
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